Physician profile
Lacy Mcclain
NPI 1427163724
$97,339.92
in general payments reported to CMS, 2019-2025
13 companies · $4,357 in 2025
The $4,357 reported for 2025 was more than what 80% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $3,959 · 2021: $9,243 · 2022: $21K · 2023: $22K · 2024: $23K · 2025: $4,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Travel and Lodging: $6,477 · Food and Beverage: $3,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $39,058.95 |
| Travel and Lodging | $6,477.28 |
| Food and Beverage | $3,020.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $96,149.20 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Baxter Healthcare | $247.45 | 2024-2025 | Preveleak |
| Medtronic, INC. | $237.28 | 2021-2025 | Avalus, Penditure |
| Abiomed | $233.02 | 2019-2025 | Impella |
| Ethicon INC. | $120.81 | 2020 | |
| Cook Medical LLC | $92.93 | 2019-2021 | |
| Edwards Lifesciences Corporation | $88.42 | 2023 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $75.58 | 2019-2023 | Bridion |
| Mallinckrodt Enterprises LLC | $28.45 | 2019 | |
| Davol INC. | $21.31 | 2022 | |
| Medtronic Vascular, INC. | $17.81 | 2020 | |
| Astellas Pharma US INC | $14.13 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lacy Mcclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.